The Ridgewood Blog Brings a Free Market Laissez-faire Point of View to Local, New Jersey State and National Issues.
photo of Michinori Kohara
the staff of the Ridgewood blog
Researchers at the Tokyo Metropolitan Institute of Medical Science are working on a COVID-19 vaccine that not only delivers lifelong immunity against the SARS-CoV-2 virus but could also be transported at room temperature to far-off corners of the world, The Japan Times reported.
the staff of the Ridgewood blog
Ridgewood NJ, Pfizer has developed a pill designed to stop Covid-19. It is now starting human trials on the drug, which showed no significant risks or safety concerns during its animal studies. The human trials will be split into three phases and run for 145 days. Another 28 days will be added to the trial period for screening and dosing. The drug attacks the spine of the SARS-CoV-2 virus and stops it from replicating in the nose, throat, and lungs. It is classed as a protease inhibitor.